1,382 Followers on Owler

BeiGene

is a biotechnology company that develops and commercializes immunotherapeutics for the treatment of cancer... Read more
OverviewCompetitorsFundingInvestmentsNews & Insights

BeiGene

is a biotechnology company that develops and commercializes immunotherapeutics for the treatment of cancer... Read more
BeiGene Chairman & CEO: John V. Oyler

Chairman & CEO

John V. Oyler

CEO Approval Rating

90/100

2010

PublicIndependent CompanyNASDAQBGNE

Pharmaceuticals & Biotechnology
BiotechnologyMedical Research & Laboratories
2836 NAICS listing

Annual Revenue
$3.8B
Employees
11,000
Funding
$2.8B
Investments
6

News

Conference Presentation
Feb 25, 2025
Marketscreener
BeiGene to Present at Upcoming Investor Conferences
Partnership
Jan 30, 2025
Clinical Trials Arena
ImmunityBio and BeiGene partner on Phase III trial of NSCLC treatment combo

BeiGene Competitors

1Innovent Biologics
2Sino Biological
3CARsgen
4EMD Serono
5TESARO
6Mabworks
7Immatics
8Five Prime
9CytomX
10Brii Bio
Unlock 7 + competitors

Trending Companies